Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Anal Neoplasm · Lassa Fever · INO

INOVIO Pharmaceuticals

INOVIO PHARMACEUTICALS, INC.

INOVIO Pharmaceuticals patent portfolio — 75 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO · NYSE Ticker
Company details
Status
Public
HQ
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
Employees
203
Programs
46
Drugs
8
Patents
75
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

INOVIO Pharmaceuticals patents

75 pharmaceutical patents indexed for INOVIO Pharmaceuticals. 0 expire within 24 months.

INOVIO Pharmaceuticals has 75 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

75 patents

Patent portfolio

Page 2 of 2

  1. US 10548971

    MERS-CoV vaccine

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10398769

    Influenza nucleic acid molecules and vaccines made therefrom

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10232030

    Vaccines for human papilloma virus and methods for using the same

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10226526

    Vaccines for human papilloma virus and methods for using the same

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10220082

    WT1 vaccine

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10207003

    Liquid pentablock co-polymer formulations for sustained delivery of therapeutics

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10166288

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10130705

    Vaccines with interleukin-33 as an adjuvant

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10087240

    DNA antibody constructs and method of using same

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10016497

    MERS-CoV vaccine

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9993545

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9987347

    Vaccines against multiple subtypes of dengue virus

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9913885

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9669091

    Vaccines having an antigen and interleukin-23 as an adjuvant

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9446114

    Cross-protective arenavirus vaccines and their method of use

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9446112

    Clostridium difficile DNA vaccine

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9399056

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9156890

    HCV vaccines and methods for using the same

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9156891

    Vaccines and methods for using the same

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9109014

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9034313

    Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8927692

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8921536

    HCV vaccines and methods for using the same

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8829174

    HCV vaccines and methods for using the same

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8535687

    Smallpox DNA vaccine and the antigens therein that elicit an immune response

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7931640

    Method for muscle delivery of drugs, nucleic acids and other compounds

    Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 6610044

    Method for genetic immunization

    Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does INOVIO Pharmaceuticals have?

75 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do INOVIO Pharmaceuticals patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.